CS logo
small CS logo
Rochester Institute for Digestive Diseases

Rochester, New York, United States

About Rochester Institute for Digestive Diseases


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Rochester Institute for Digestive Diseases


During the past decade, Rochester Institute for Digestive Diseases conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Rochester Institute for Digestive Diseases" #1 sponsor was "Abbott" with 3 trials, followed by "Mesoblast, Inc." with 2 trials sponsored, "Synta Pharmaceuticals Corp." with 2 trials sponsored, "Biogen" with 1 trials sponsored and "Ionis Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Rochester Institute for Digestive Diseases" #1 collaborator was "Elan Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Rochester Institute for Digestive Diseases


According to Clinical.Site data, the most researched conditions in "Rochester Institute for Digestive Diseases" are "Crohn's Disease" (8 trials) and "Hepatitis C, Chronic" (1 trials). Many other conditions were trialed in "Rochester Institute for Digestive Diseases" in a lesser frequency.

Clinical Trials Intervention Types at Rochester Institute for Digestive Diseases


Most popular intervention types in "Rochester Institute for Digestive Diseases" are "Drug" (7 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Adalimumab (D2E7)" (1 trials), "Adalimumab 40 mg eow or ew" (1 trials), "DB adalimumab 40 mg eow" (1 trials) and "DB adalimumab 40 mg ew" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Rochester Institute for Digestive Diseases


The vast majority of trials in "Rochester Institute for Digestive Diseases" are 9 trials for "All" genders.

Clinical Trials Status at Rochester Institute for Digestive Diseases


Currently, there are NaN active trials in "Rochester Institute for Digestive Diseases". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Rochester Institute for Digestive Diseases, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Rochester Institute for Digestive Diseases, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".